Could a drug make colon cancer surgery unnecessary?
NCT ID NCT07409844
Summary
This study is testing whether giving an immunotherapy drug (pembrolizumab) before surgery can shrink tumors enough to allow some patients with a specific type of early-stage colon cancer to avoid major surgery. The goal is to see if patients whose cancer disappears after the drug treatment can be safely monitored with regular check-ups instead of having surgery. The study will also compare quality of life between patients who avoid surgery and those who need it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zealand University Hospital
Køge, 4600, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.